N-acetylcysteine as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia: a randomized, double-blind, placebo-controlled study M Farokhnia, A Azarkolah, F Adinehfar, MR Khodaie-Ardakani, ... Clinical neuropharmacology 36 (6), 185-192, 2013 | 175 | 2013 |
Relationship between job burnout and work performance in a sample of Iranian mental health staff Z Ashtari, Y Farhady, MR Khodaee African journal of psychiatry 12 (1), 71-74, 2009 | 155 | 2009 |
Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study MR Khodaie-Ardakani, O Mirshafiee, M Farokhnia, M Tajdini, ... Psychiatry research 215 (3), 540-546, 2014 | 110 | 2014 |
Effect of inbreeding on intellectual disability revisited by trio sequencing K Kahrizi, H Hu, M Hosseini, VM Kalscheuer, Z Fattahi, M Beheshtian, ... Clinical genetics 95 (1), 151-159, 2019 | 69 | 2019 |
Riluzole combination therapy for moderate-to-severe major depressive disorder: a randomized, double-blind, placebo-controlled trial E Salardini, A Zeinoddini, P Mohammadinejad, MR Khodaie-Ardakani, ... Journal of psychiatric research 75, 24-30, 2016 | 53 | 2016 |
Raloxifene adjunctive therapy for postmenopausal women suffering from chronic schizophrenia: a randomized double-blind and placebo controlled trial G Kianimehr, F Fatehi, S Hashempoor, MR Khodaei-Ardakani, F Rezaei, ... DARU Journal of Pharmaceutical Sciences 22, 1-7, 2014 | 52 | 2014 |
The effects of pioglitazone adjuvant therapy on negative symptoms of patients with chronic schizophrenia: a double‐blind and placebo‐controlled trial N Iranpour, A Zandifar, M Farokhnia, A Goguol, H Yekehtaz, ... Human Psychopharmacology: Clinical and Experimental 31 (2), 103-112, 2016 | 45 | 2016 |
A double-blind, placebo controlled, randomized trial of riluzole as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia M Farokhnia, M Sabzabadi, H Pourmahmoud, MR Khodaie-Ardakani, ... Psychopharmacology 231, 533-542, 2014 | 45 | 2014 |
Caregivers’ Quality of Life and Quality of Services for Children with Cancer: A Review from Iran H Sajjadi, M Vameghi, MMR Ghazinour Global journal of health science 5 (3), p173, 2013 | 45 | 2013 |
A placebo-controlled study of tropisetron added to risperidone for the treatment of negative symptoms in chronic and stable schizophrenia M Noroozian, S Ghasemi, SMR Hosseini, A Modabbernia, ... Psychopharmacology 228, 595-602, 2013 | 43 | 2013 |
Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double‐blind randomized placebo‐controlled study A Amiri, AA Noorbala, AA Nejatisafa, A Ghoreishi, MK Derakhshan, ... Human Psychopharmacology: Clinical and Experimental 23 (2), 79-86, 2008 | 43 | 2008 |
Prevalence of metabolic syndrome among an Iranian cohort of inpatients with schizophrenia O Rezaei, MR Khodaie-Ardakani, MH Mandegar, E Dogmehchi, ... The International Journal of Psychiatry in Medicine 39 (4), 451-462, 2009 | 35 | 2009 |
A placebo-controlled study of raloxifene added to risperidone in men with chronic schizophrenia AMR KHODAIE, M Khosravi, R Zarinfard, S Nejati, A Mohsenian, ... ACTA MEDICA IRANICA 53 (6), 337-345, 2015 | 33 | 2015 |
Effect of bumetanide, a selective NKCC1 inhibitor, on hallucinations of schizophrenic patients; a double-blind randomized clinical trial. R Rahmanzadeh, S Eftekhari, A Shahbazi, M Khodaei Ardakani, ... Elsevier Science, 2017 | 32 | 2017 |
Granisetron as an add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study MR Khodaie-Ardakani, S Seddighi, A Modabbernia, F Rezaei, B Salehi, ... Journal of psychiatric research 47 (4), 472-478, 2013 | 31 | 2013 |
A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia S Salimi, A Fotouhi, A Ghoreishi, MK Derakhshan, MR Khodaie-Ardakani, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 32 (3), 726-732, 2008 | 30 | 2008 |
Sezary syndrome, Kaposi sarcoma and generalized dermatophytosis 15 years after sulfur mustard gas exposure SN Emadi, F Babamahmoodi, Z Poursaleh, SS Sayad-Noori, MR Soroush, ... Journal of dermatological case reports 6 (3), 86, 2012 | 28 | 2012 |
Pattern of smoking and nicotine dependence in patients with psychiatric disorders HS Milani, R Kharaghani, M Safa, R Samadi, MH Farhadi, MRK Ardakani, ... Tanaffos 11 (1), 55, 2012 | 23 | 2012 |
Alterations of subcortical brain structures in paradoxical and psychophysiological insomnia disorder F Emamian, M Mahdipour, K Noori, M Rostampour, SB Mousavi, ... Frontiers in psychiatry 12, 661286, 2021 | 22 | 2021 |
Investigate the Prevalence of Depression and its association with Demographic variables in employees A Musarezaie, T Momeni-Ghalehghasemi, N Musarezaie, M Moeini, ... Iranian Journal of Psychiatric Nursing 2 (3), 37-45, 2014 | 19 | 2014 |